Philadelphia, PA, April 26, 2010 – Arlene Forastiere, MD, SVP of Medical Affairs at eviti, Inc., and an internationally recognized expert in the treatment of cancers of the head, neck, larynx and esophagus, and professor at Johns Hopkins University School of Medicine, has accepted an invitation to participate on the Northeast Business Group on Health’s (NEBGH) panel discussion covering advancements in the cancer care benefit. The event is part of the NEBGH’s cancer series – Addressing Cancer in the Workplace – to be held at the City University of New York Graduate Center on April 27, 2011.
Dr. Forastiere will serve on the panel along with Lee Newcomer, MD, SVP-Oncology, UnitedHealthcare and Richard Popiel, MD, VP and Chief Medical Officer, Horizon Blue Cross Blue Shield of NJ. Discussions will be moderated by Michael Rendel, MD, Medical Director, Goldman Sachs & Co.
The panel will address such questions as:
- How can employers achieve value in an era of escalating cost in cancer care?
- Can employers evaluate and provide access to high quality, safety and “best care” related to cancer treatments??
- What are leading employers doing to tackle cancer as a workplace issue??
NEBGH is a network of employers, providers, insurers and other organizations working together to improve the quality and reduce the cost of health care in New York, New Jersey, Connecticut and Massachusetts.
“Statistics show that 32% of cancer cases do not meet evidence-based medicine. At a cost of $135,000 per cancer case, employers are seeking means to improve care and reduce costs. This is a great opportunity for us to bring stakeholders together and share information to help employers make informed decisions regarding cancer care for their employees,” said Dr. Forastiere.